Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.

COVID-19 SARS-CoV-2 United States coronaviruses frontline workers mRNA vaccines omicron variant reinfection respiratory infection risk factors vaccine effectiveness viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 27 1 2023
medline: 25 2 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

In a cohort of essential workers in the United States previously infected with SARS-CoV-2, risk factors for reinfection included being unvaccinated, infrequent mask use, time since first infection, and being non-Hispanic Black. Protecting workers from reinfection requires a multipronged approach including up-to-date vaccination, mask use as recommended, and reduction in underlying health disparities.

Identifiants

pubmed: 36703252
doi: 10.3201/eid2903.221314
pmc: PMC9973698
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

599-604

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM139779
Pays : United States
Organisme : CDC HHS
Pays : United States

Références

JMIR Res Protoc. 2021 May 26;:
pubmed: 34057904
N Engl J Med. 2022 Mar 31;386(13):1288-1290
pubmed: 35139269
Influenza Other Respir Viruses. 2022 May;16(3):585-593
pubmed: 35023288
N Engl J Med. 2022 May 12;386(19):1855-1857
pubmed: 35385628
JAMA. 2021 Feb 23;325(8):719-720
pubmed: 33480972
Transplantation. 2022 Aug 1;106(8):1622-1628
pubmed: 35502801
N Engl J Med. 2022 Jun 9;386(23):2201-2212
pubmed: 35613036
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428
MMWR Morb Mortal Wkly Rep. 2022 Apr 15;71(15):549-555
pubmed: 35421077
JMIR Res Protoc. 2021 Dec 3;10(12):e31574
pubmed: 34662287
Ann Intern Med. 2022 Apr;175(4):547-555
pubmed: 35073157
Science. 2022 May 6;376(6593):eabn4947
pubmed: 35289632
Lancet. 2021 Mar 27;397(10280):1204-1212
pubmed: 33743221
JAMA. 2020 Oct 13;324(14):1389-1390
pubmed: 32936212

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH